Clincosm LogoSign in Get a demo

ovarian cancer

Showing NaN - NaN of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Canada, United Kingdom, United States (SGI-110, Treatment of Choice (topotecan, pegylated liposomal

Completed
Has Results
  • Ovarian Cancer
  • Los Angeles, California
  • +23 more
Apr 30, 2021

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

Completed
  • Endometrial Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Apr 20, 2021

Cancer Diagnosis and Treatment on Everyday Life

Active, not recruiting
  • Breast Cancer Female
  • +17 more
    • Aberystwyth, United Kingdom
    • +110 more
    Mar 16, 2021

    Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,

    Terminated
    • Advanced Solid Tumors
    • +2 more
    • SY-1365 (Part 1)
    • +5 more
    • Birmingham, Alabama
    • +19 more
    Mar 5, 2021

    Ovarian Cancer, Breast Cancer Trial in Boston, New York, Houston (BKM120 and Olaparib, BYL719 and Olaparib)

    Completed
    • Ovarian Cancer
    • Breast Cancer
    • BKM120 and Olaparib
    • BYL719 and Olaparib
    • Boston, Massachusetts
    • +4 more
    Feb 8, 2021

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

    Completed
    Has Results
    • Ovarian Cancer
    • +3 more
    • San Francisco, California
    • +15 more
    Jan 19, 2021

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)

    Completed
    • Ovarian Cancer
    • +2 more
    • Anchorage, Alaska
    • +148 more
    Dec 11, 2020

    Continuation of Follow-up of DES-Exposed Cohorts

    Completed
    • Breast Cancer
    • +4 more
      • Boston, Massachusetts
        Boston University School of Public Health
      Nov 13, 2020

      Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

      Completed
      Has Results
      • Epithelial Ovarian Cancer
      • +3 more
      • Mirvetuximab soravtansine
      • +3 more
      • Birmingham, Alabama
      • +130 more
      Sep 24, 2020

      Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Tumor collection)

      Completed
      • Ovarian Cancer
      • +2 more
      • Tumor collection
      • Boston, Massachusetts
      • +3 more
      Sep 9, 2020

      B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

      Completed
      • B-cell Malignancies
      • +7 more
      • Nivolumab (Phase 1)
      • +4 more
      • Birmingham, Alabama
      • +23 more
      Aug 26, 2020

      Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Paclitaxel, Carboplatin, Avastin)

      Active, not recruiting
      • Ovarian Cancer
      • +2 more
      • Baltimore, Maryland
      • +4 more
      Aug 17, 2020

      Ovarian Cancer Trial in Worldwide (carboplatin, paclitaxel, Avelumab)

      Terminated
      Has Results
      • Ovarian Cancer
      • Alabaster, Alabama
      • +319 more
      Jun 19, 2020

      Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)

      Terminated
      • Sarcoma
      • +3 more
      • CMB305
      • +2 more
      • Santa Monica, California
      • +7 more
      Jun 29, 2020

      Ovarian Cancer Trial in United States (CRLX101, Paclitaxel)

      Terminated
      • Ovarian Cancer
      • Boston, Massachusetts
      • +6 more
      May 26, 2020

      Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

      Terminated
      Has Results
      • Melanoma
      • +4 more
      • Scottsdale, Arizona
      • +11 more
      Feb 18, 2020

      Ovarian Cancer Trial in Boston (Group Session, Telephone Coaching Session, Webinar)

      Completed
      • Ovarian Cancer
      • Group Session
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Feb 27, 2020

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Boston (Paclitaxel, Ricolinostat, Bevacizumab)

      Terminated
      Has Results
      • Ovarian Cancer
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Nov 7, 2019

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United Kingdom, United States (Ramucirumab)

      Completed
      Has Results
      • Ovarian Cancer
      • +2 more
      • Ramucirumab
      • Hollywood, Florida
      • +12 more
      Sep 10, 2019

      Ovarian Cancer Trial in Japan, United States (carboplatin, paclitaxel)

      Completed
      Has Results
      • Ovarian Cancer
      • Birmingham, Alabama
      • +150 more
      May 23, 2019

      Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)

      Terminated
      • Ovarian Cancer
      • SC-003
      • SC-003 in combination with ABBV-181
      • Fayetteville, Arkansas
      • +15 more
      Jan 2, 2019

      Ovarian Cancer Trial in Worldwide (Pimasertib once daily, Pimasertib , SAR245409 )

      Completed
      Has Results
      • Ovarian Cancer
      • Pimasertib once daily
      • +4 more
      • Augusta, Georgia
      • +33 more
      Nov 26, 2018

      Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Boston (Paclitaxel, Carboplatin)

      Terminated
      Has Results
      • Ovarian Cancer
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Aug 10, 2018

      Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Bevacizumab, Cyclophosphamide)

      Completed
      Has Results
      • Ovarian Cancer
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Aug 10, 2018

      Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Sunitinib)

      Completed
      Has Results
      • Ovarian Cancer
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Jul 26, 2018